Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation

Following allogeneic blood and marrow transplantation (BMT), graft-versus-host disease (GvHD) continues to represent a significant cause of treatment failure, despite the routine use of conventional, mainly calcineurin inhibitor-based prophylaxis. Recently, post-transplant cyclophosphamide (PTCy) ha...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Louis Williams, Frank Cirrone, Kelli Cole, Maher Abdul-Hay, Leo Luznik, Ahmad Samer Al-Homsi
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Frontiers Media S.A. 2020-04-01
Rangatū:	Frontiers in Immunology
Ngā marau:	GvHD prevention post-transplant cyclophosphamide matched-related donor matched unrelated donor bortezomib calcineurin inhibitor-free
Urunga tuihono:	https://www.frontiersin.org/article/10.3389/fimmu.2020.00636/full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!